AAHRPP Clinical Research & IRB Accreditation Consulting

What Is AAHRPP Accreditation?

AAHRPP — the Association for the Accreditation of Human Research Protection Programs — is the premier accrediting body for Human Research Protection Programs (HRPPs) and Institutional Review Boards (IRBs) in the United States and internationally. AAHRPP accreditation is a voluntary, peer-driven credential that demonstrates an organization's commitment to the highest ethical and operational standards in human subjects research.

The significance of this credential has grown substantially over the past decade. As of April 2025:

• 245 parent organizations hold AAHRPP accreditation — 205 in the US and 40 internationally — representing more than 600 distinct research entities globally.
• 85% or more of top NIH-funded academic medical centers are AAHRPP accredited or in process.
• 70% of US medical colleges hold the credential.
• All 13 major independent commercial IRBs in the US hold AAHRPP accreditation — because pharmaceutical and medical device sponsors have made it a prerequisite for site selection.

For community hospitals expanding into oncology and cardiovascular trials, for mid-tier universities seeking to attract commercial sponsors, and for independent IRBs serving multi-site networks, AAHRPP accreditation has moved from a differentiator to a competitive necessity.

Why AAHRPP Accreditation Is Increasingly Non-Optional

Several concurrent federal regulatory changes and market forces are accelerating AAHRPP adoption in 2025–2026:

Federal Single IRB Mandate

Under NIH policy and the revised Common Rule, multi-site cooperative research must rely on a single centralized IRB (sIRB) of record. AAHRPP accreditation is a practical prerequisite for institutions seeking to serve as sIRB — because relying institutions almost universally require it before ceding review authority. Organizations without AAHRPP accreditation are structurally excluded from the most valuable multi-site research networks.

Pharmaceutical and Medical Device Sponsor Requirements

Virtually all commercial sponsors now require independent IRBs to be AAHRPP accredited as a condition of site selection. AAHRPP accreditation is the primary filter applied when pharmaceutical companies, biotechs, and medical device manufacturers evaluate whether to route trials to a given institution or IRB. For institutions seeking to grow their clinical trial revenue, AAHRPP is not optional.

FDA Harmonization (May 2024)

FDA updates to 21 CFR 50 and 56 — aligning regulations with the revised Common Rule — changed requirements for cooperative research governance and mandated "key information" summaries at the beginning of all informed consent documents. Organizations with AAHRPP accreditation had structured processes in place. Those without it scrambled to retrofit new requirements into inconsistent policy infrastructures.

PHS Research Misconduct Rule (Effective January 1, 2025)

The first substantial update to PHS research misconduct regulations in decades fundamentally altered how institutions must investigate, document, and report research integrity violations to federal authorities. This is exactly the type of systemic policy change that creates gap findings in AAHRPP evaluations — organizations that had not updated their misconduct policies before this effective date now carry documentation risk.

IRS Compensation Reporting Threshold Change (Effective January 1, 2026)

The mandatory reporting threshold for research participant compensation was increased from $600 to $2,000 per calendar year. This requires HRPP policy overhauls for financial disclosure, accounting SOPs, and informed consent templates. Organizations mid-accreditation cycle must update their documentation before their next survey — or risk deficiency findings on newly non-compliant forms.

UNC-Chapel Hill Reliance Requirements

UNC-Chapel Hill's institutional policy generally requires external IRBs to hold AAHRPP accreditation before UNC will cede review authority. This creates a regional economic mandate with downstream effects across the entire North Carolina research network — and is the template for how similar reliance requirements may expand to other research-intensive institutions.

The AAHRPP Evaluation Instrument: Three Domains

AAHRPP evaluates organizations against a hierarchical architecture of Domains, Standards, and Elements that integrates US federal mandates with ICH-GCP E6 guidelines. The three-domain structure reflects the full organizational ecosystem of human research protection:

Domain I: The Organization

Evaluates the institution's HRPP at the systemic level — leadership commitment, resource allocation, policy infrastructure, quality improvement mechanisms, conflict of interest management, and community engagement. Domain I Standards assess whether the organization has created the conditions under which ethical research can occur.

The most common Domain I deficiencies IHS identifies during gap analysis:

• Failure to adhere to own written policies (Standard I-5): Organizations purchase off-the-shelf SOP templates but fail to integrate them culturally — creating a mismatch between what the manual says and what staff actually do. This is the single most commonly cited AAHRPP deficiency.
• Inadequate quality assessment metrics (Standard I-5): Organizations rely almost exclusively on speed metrics (turnaround times) rather than substantive deliberative quality or ethical rigor metrics — which is precisely what AAHRPP peer reviewers look for.
• Conflict of interest management failures (Standard I-6): Inadequate financial disclosure documentation, failure to enforce COI management plans, or allowing conflicted members to participate during protocol deliberation.
• Lack of formalized community engagement (Standard I-4): No systemic programs to engage the local community, solicit participant feedback, or incorporate public perspectives into research design.

Domain II: The IRB or Ethics Committee

Evaluates the IRB's operational practices — membership composition, documentation quality, review procedures, and management of unanticipated problems. Domain II is where paper-based IRBs most frequently fail: peer reviewers conduct intensive random record reviews of active and closed study files to verify that documented decisions reflect substantive deliberation.

The most common Domain II deficiencies:

• Missing IRB-specific documentation in study files: Absent formal approval letters, missing signatures, and — critically — meeting minutes that fail to document the risk-benefit rationale for controversial protocols.
• Incomplete records: Blank mandatory fields on routing forms, missing data in regulatory binders, and incomplete historical records of study modifications.
• Inconsistencies in protocol materials: Protocol details that contradict what the informed consent document says — a finding that signals the IRB is rubber-stamping rather than reviewing.

Domain III: The Researchers and Research Staff

Evaluates whether the humans conducting research — investigators and their staff — understand and apply HRPP policies in daily practice. Domain III findings often surprise organizations that assumed strong IRB policies automatically translated to compliant investigator behavior.

The most common Domain III deficiencies:

• Unauthorized methods or materials: Researchers deploying recruitment advertisements, questionnaires, or procedural variations that were never formally approved by the IRB.
• Incorrect consent form versions: Signed ICDs that do not match the most recently approved version, or failure to provide participants with an executed copy.
• Unauthorized study personnel: Individuals working on a protocol, interacting with subjects, or accessing PHI who are not explicitly approved by the IRB or listed on the delegation of authority log.

The AAHRPP Accreditation Process: What to Expect

Phase 1: Comprehensive Program Evaluation and Gap Analysis (Months 1–3)

IHS consultants review all existing institutional policies, conduct extensive interviews with the Institutional Official (IO) and IRB Chair, and observe an active convened IRB meeting. Gaps against the current AAHRPP Evaluation Instrument are formally identified and triaged across all three Domains. The output is a prioritized remediation roadmap with specific policy, procedure, and operational recommendations for each identified gap.

Phase 2: Policy Development and SOP Overhaul (Months 4–9)

The heaviest operational lift. IHS guides your organization through rewriting or adopting entirely new policies to ensure your written documentation aligns precisely with AAHRPP standards. Custom SOPs replace off-the-shelf templates that have never been integrated into daily operations. This phase addresses the most common AAHRPP deficiency — the gap between what an organization's policy says and what its staff actually does.

Phase 3: Step 1 Application Submission (Month 10)

Formal digital submission through the AAHRPP portal of Section A (organization profile) and Section C/D (complete compendium of written policies and supporting documents), with each document explicitly mapped to its corresponding AAHRPP standard. IHS manages the submission package and verifies that all required documentation categories are complete before submission.

Phase 4: Response to Written Evaluation (Months 11–13)

An off-site AAHRPP peer reviewer assesses submitted documentation and generates a deficiency report. IHS works with your team to rapidly address cited deficiencies, revise policies, and submit clarifying justifications within AAHRPP's response windows. Organizations without consulting support at this phase frequently lose weeks to misdirected remediation efforts that do not satisfy reviewer concerns.

Phase 5: Mock Survey and Site Visit Preparation (Month 14)

IHS conducts realistic mock interviews with investigators, IRB staff, and executives to ensure your personnel can articulate how they apply new policies in daily practice — not just reference them theoretically. This is the phase that most directly predicts site visit outcomes. AAHRPP site visitors are peer professionals who know the difference between staff who have internalized new policies and staff who memorized answers for the site visit.

Phase 6: AAHRPP Site Visit (Month 15)

A 2-to-3 day intensive on-site or remote audit by AAHRPP peer reviewers. Site visitors interview executives, IRB chairs, members, and active researchers. They conduct extensive random record reviews of active and closed study files to verify that practices match written policies. IHS provides on-site support for site visit logistics and real-time consultation during the visit.

Phase 7: Draft Report Response and Council Review (Months 16–18)

Following the site visit, the institution develops and submits a formal corrective action plan addressing site visit findings. The AAHRPP Council on Accreditation reviews the draft site visit report, institutional responses, and makes the final binding accreditation determination. IHS prepares the corrective action plan and coordinates the response to ensure each finding is addressed systematically.

AAHRPP Fee Structure

AAHRPP application fees are tiered by active protocol volume from the preceding 12 months. This is public information that most consulting firms do not publish — IHS provides it transparently so organizations can budget accurately before beginning the process.

Level	Active Protocols	Application Fee	Annual Fee
Level 0	Relies entirely on external AAHRPP IRBs	$8,384	$3,750
Level 1	1–100 protocols	$13,352	$5,960
Level 2	101–500 protocols	$20,183	$8,170
Level 3	501–1,000 protocols	$25,668	$10,340
Level 4	1,001–1,500 protocols	$32,189	$12,500
Level 5	1,501–2,000 protocols	$38,088	$14,140
Level 10	4,001–4,500 protocols	$68,310	$22,600
Level 16	7,001+ protocols	$93,978	$27,790

Pre-payment incentive: Organizations that prepay the application fee become "clients" of AAHRPP, locking in the current fee structure through the end of the following year and gaining unlimited AAHRPP staff consultation during preparation. Reaccreditation (first renewal at 3 years, then every 5 years) is covered by ongoing annual maintenance fees — no separate application fee is required.

IHS consulting engagements for AAHRPP accreditation are scoped and priced based on the organization's current compliance posture, protocol volume, and number of research sites. Comprehensive end-to-end engagements typically range from $50,000 to $150,000; targeted gap remediation and mock survey preparation are available at lower scope and cost.

The IHS Differentiator: Accreditation Depth for Mid-Market Research Institutions

IHS is a specialized healthcare accreditation consulting firm with 25+ years of experience navigating URAC, ACHC, and now AAHRPP accreditation standards. We are not a large consulting firm that offers AAHRPP as one service line among dozens. We are not a commercial IRB attempting to monetize consulting as an ancillary product. We are an independent accreditation consulting firm whose entire practice is built on one competency: helping organizations understand exactly what peer reviewers are looking for and building the systems to satisfy that standard before the site visit.

The mid-market gap in AAHRPP consulting is real. Huron Consulting Group's HRPP Toolkit is priced and scoped for massive ground-up overhauls at large research universities. Advarra's consulting arm is designed to feed its commercial IRB business. WCG Clinical is primarily an IRB of record, not a consulting firm. HRP Consulting Group is a boutique firm with limited capacity and geographic reach.

IHS serves community hospitals expanding research programs, mid-tier universities building HRPP infrastructure from the ground up, and independent IRBs that need accreditation to compete for sponsor relationships — organizations that need substantive expertise without enterprise-firm pricing.

Our specific differentiators:

• Culture of conscience, not checkbox compliance: The most common AAHRPP deficiency — failure to adhere to own written policies — is not solved by better documentation. It is solved by cultural integration. IHS builds compliance programs that staff actually follow, not policies that pass on paper and fail in practice.
• Domain I + Domain III combined gap remediation: Most consultants focus on Domain II (IRB documentation) because that is where paper audits fail. IHS addresses the full three-domain picture, with particular attention to the cultural and operational gaps between Domain I policy commitments and Domain III researcher behavior.
• Transparent cost and timeline guidance: IHS publishes AAHRPP fee schedules and realistic timeline estimates. No competitor does this. Organizations should know what they are committing to before they begin.
• Coordinated accreditation strategy: Organizations pursuing AAHRPP alongside URAC, ACHC, or other accreditations benefit from coordinated policy development that reduces redundant work across programs. IHS structures engagements to minimize total compliance burden.

Frequently Asked Questions

Do all research institutions need AAHRPP accreditation?

AAHRPP accreditation is voluntary — federal regulations do not mandate it. However, it is effectively required for institutions seeking to serve as sIRB of record for multi-site NIH-funded research, for independent IRBs seeking commercial sponsor relationships, and increasingly for community hospitals seeking to attract clinical trial activity. Organizations that conduct only minimal research with no commercial sponsor involvement may not need it. IHS can help organizations assess whether the credential is warranted given their research portfolio and growth objectives.

What is the difference between AAHRPP accreditation and IRB registration?

IRB registration with OHRP (Office for Human Research Protections) is a federal requirement for any IRB that reviews federally funded research or research subject to FDA regulations. Registration is a baseline administrative requirement — not a quality credential. AAHRPP accreditation is a voluntary, peer-evaluated quality standard that goes substantially beyond registration requirements. An institution can be IRB-registered and fail an AAHRPP evaluation on multiple dimensions.

What happens if we fail the AAHRPP site visit?

AAHRPP does not issue binary pass/fail determinations after the site visit. The Council on Accreditation reviews the site visit report and institutional responses, then makes one of several determinations: full accreditation, accreditation with requirements (issues that must be resolved within a defined period), or deferral pending additional corrective action. Most organizations that have invested in thorough preparation receive accreditation with requirements rather than outright deferral. IHS supports the corrective action plan development regardless of the determination outcome.

Work With IHS on Your AAHRPP Accreditation

IHS provides AAHRPP accreditation consulting for universities, academic medical centers, health systems, independent IRBs, and community hospitals building research programs. Our engagements begin with a comprehensive gap analysis that gives your organization a realistic picture of where you stand against current AAHRPP standards before you commit to the full process.

Schedule Your AAHRPP Gap Analysis